Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2026-02-04 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Regulatory Filings Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Stock Exchange (HKEX). This is a standard regulatory filing required by the Exchange Listing Rules to report movements in securities, share capital, and public float sufficiency. It does not fit into specific categories like 'Share Issue' (SHA) or 'Transaction in Own Shares' (POS) because it is a comprehensive monthly summary of all security movements rather than a specific event announcement. Therefore, it is classified as a Regulatory Filing (RNS).
2026-02-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Regulatory Filings Classification · 100% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory filing used by listed companies in Hong Kong to report monthly movements in securities, including share capital, share options, and other equity changes. Since it is a recurring regulatory disclosure of share capital movements and does not fit into specific categories like 'Annual Report' or 'Earnings Release', it is classified as a Regulatory Filing (RNS).
2026-01-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Stock Exchange. This specific form is used by listed companies to report monthly movements in their securities, including changes in authorized share capital, issued shares, and treasury shares. While it relates to share capital, it is a standard regulatory reporting requirement for Hong Kong-listed companies rather than a specific ad-hoc share issue or repurchase announcement. Given the nature of the document as a recurring regulatory filing for securities movements, it falls under the 'Regulatory Filings' category.
2026-01-02 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding the 'Completion of Placing of New Shares' by 3SBio Inc. It details the issuance of new shares, the use of proceeds, and the resulting change in the company's shareholding structure. This falls under the category of capital changes and share issuance, which is specifically defined as 'Share Issue/Capital Change' (SHA).
2025-12-09 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details a specific change in the company's issued share capital due to a placing/subscription event. According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2025-12-09 English
TERMS OF REFERENCE OF NOMINATION COMMITTEE
Governance Information Classification · 100% confidence The document is titled 'Terms of Reference of Nomination Committee' for Hongkong Chinese Limited. It outlines the internal governance structure, duties, and procedures of a board committee. This type of document falls under corporate governance policies and internal rules, which is best classified as Governance Information (CGR).
2025-12-09 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.